H S is a linear polysaccharide with a complex structure. HS varies considerably in size, position, and degree of sulfation, as well as in epimerization of uronic acid in different cells, tissues, and developmental stages. Such structural complexity and spatial and temporal expression patterns form the basis of the multifaceted functions of HS.
Biochemical studies with small-sized HS oligosaccharides and chemically modified heparins, a highly sulfated form of HS, have shown that HS interacts with protein ligands through its unique binding sites, which consist of relatively small tracts of variable modifications, including N-sulfation (NS), 6-O-sulfation (6S), and 3-O-sulfation (3S) of glucosamine residues; 2-O-sulfation (2S) of uronic acid; and epimerization of glucuronic acid to iduronic acid (IdoA), in specific arrangements [1] [2] [3] (Fig. 1a ). Extension of the biochemical findings to a cellular level is essential for a better understanding of the structure-function relationships and unique biological and pathological roles of HS. However, this has been challenging owing to the length of native HS and its propensity to interact simultaneously with a ligand and the ligand's receptor or to harbor multiple copies of binding sites for a ligand 1, 4, 5 . In addition, the relative importance of fine structures versus overall sulfation of HS in interaction with a protein ligand remains a fundamental question in HS biology [6] [7] [8] [9] . Furthermore, anti-HS phage display antibodies have been widely used to probe specific HS structures in situ, but their native HS epitope structures remain unclear. Better characterization of the HS epitope features might yield valuable new information for future antibody-based studies.
Here we report the development of an HS-mutant mouse lung endothelial cell (MLEC) library that enabled us to address some of the aforementioned fundamental HS biology issues, and which represents a novel test platform for systematic interrogation of the roles and related structures of HS in a cellular context. Sulf1 −/− ;Sulf2 −/− cell lines. All seven directly derived MLEC lines expressed endothelial cell markers CD31 and VEGFR2, which confirmed their endothelial cell identity ( Supplementary Fig. 2 ). The HS-gene expression patterns in the Ext1 f/f , Ndst1 f/f , Hs2st1 f/f , Hs6st1 f/f , and Sulf1 f/f ;Sulf2 f/f MLEC lines were similar to those in primary MLECs (Fig. 1b,c and Supplementary Fig. 3 ), which indicated that the derived mutant cell lines might closely reflect HS structure alterations in vivo after targeted gene deletion. We did not collect the mice deficient for Glce, Hs3st1, or Hs3st4 because of their embryonic lethality or unavailability. Instead, we transiently cotransfected the Ndst1 f/f MLEC line with Cas9 and guide RNA (gRNA) specific for Glce, Hs3st1, or Hs3st4 ( Supplementary Figs. 1 and 4) . After screening for induced genomic insertion/deletion (indel) mutations and confirming the indels by sequencing the gRNA-targeted regions, we obtained Glce −/− , Hs3st1 −/− , Hs3st4 −/− , and Hs3st1 −/− ;Hs3st4 −/− MLEC lines ( Supplementary Fig. 4 ). By deleting HS-expressing genes individually or in combination, we developed an HS-mutant MLEC library containing a total of 18 cell lines and harboring alterations of all HS modification types ( Table 1) .
Characterization of HS structure expression in mutant MLECs.
We next characterized the generated mutant cells to understand HS alteration after HS-gene deletion. As we reported previously [10] [11] [12] , Ext1 deletion decreases HS expression, as reflected by decreased staining for anti-HS (clone 10E4) ( Fig. 2a) . The other HS-mutant cell lines all expressed HS. We analyzed them for HS disaccharide Hs6st1, -2, -3  Glce   Hs3st1,-2, -3a,  -3b, -4, -5, -6   Ndst1, -2, -3, -4   Ext1  Ext2  Hs2st1   Sulf1, -2   Core  protein   α4  α4  α4  α4  α4  α4  α4  α4  α4  α4  α4  α4  α4  α4  β4  β4  β4  β4  β4  β3  β3  β4 where "a" indicates the average). We generated the Glce −/− , Hs3st1 −/− , Hs3st4 −/− and Hs3st1 −/− ;Hs3st4 −/− lines via CRISPR-Cas9 technology, and used the parent Ndst1 f/f line as the wild-type control. We first examined samples with alterations in Ndst-family genes. HS in Ndst1 −/− cells showed a 40-60% reduction in NS, 2S, and 6S compared with levels in the control (NS 58.7%, 2S 17.3%, and 6S 16.4% in Ndst1 f/f , versus NS 22.7%, 2S 5.2%, and 6S 10.0% in Ndst1 −/− ) ( Fig. 2b , Table 1 ). HS in Ndst2 −/− cells showed a less pronounced reduction in these modifications, and HS in Ndst1 −/− ;Ndst2 −/− cells showed decreased sulfation modification (NS 56.8%, 2S 17.7%, and 6S 17.0% in WTa; NS 39.1%, 2S 10.3%, and 6S 16.4% in Ndst1 f/f ;Ndst2 −/− ; NS 2.9%, 2S 2.5%, and 6S 3.5% in Ndst1 −/− ;Ndst2 −/− ) ( Fig. 2c , Table 1 ). The overall sulfation was reduced by 59.6% for Ndst1 −/− HS, 29.0% for Ndst2 −/− HS, and 88.6% for Ndst1 −/− ;Ndst2 −/− HS compared with that in the control. These Ndst mutants could be used to determine the contribution of both NS and overall sulfation to ligand binding and downstream signaling activation in cells. However, caution would need to be taken, as Ndst-deficient HS has reduced levels of 2S and 6S.
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Glce and Hs2st1 are the only members of their gene family that are expressed in mice. Glce −/− HS showed reduced 2S and increased NS and 6S (NS 58.7%, 2S 17.3%, and 6S 16.4% for Ndst1 f/f versus NS 72.5%, 2S 6.8%, and 6S 33.5% for Glce −/− ) ( Fig. 2d , Table 1 ). Hs2st1 −/− HS showed alterations in disaccharide composition similar to those of Glce −/− HS, except with a complete lack of 2S (NS 59.1%, 2S 18.7%, and 6S 17.6% for Hs2st1 f/f versus NS 72.2%, 2S 0%, and 6S 30.0% for Hs2st1 −/− ) ( Fig. 2e , Table 1 ). Glce −/− and Hs2st1 −/− HS showed increased overall sulfation compared with levels in controls (14.5% and 7.3%, respectively). The Glce −/− and Hs2st1 −/− cells could be applied to specifically determine the necessity of IdoA and 2S versus that of the overall sulfation level for ligand binding and downstream signaling, respectively.
The 6S alteration is codetermined by Hs6st and Sulf genes. Hs6st1 −/− HS showed reduced 6S compared with levels in controls (NS 54.4%, 2S 17.6%, and 6S 15.0% for Hs6st1 f/f versus NS 58.1%, 2S 19.2%, and 6S 8.4% for Hs6st1 −/− ) ( Fig. 2f , Table 1 ). Hs6st2 −/− HS had a normal disaccharide composition, whereas Hs6st1 −/− ;Hs6st2 −/− HS completely lacked 6S and showed increases in NS and 2S (NS 56.8%, 2S 17.7%, and 6S 17.0% for WTa; NS 54.5%, 2S 13.3%, and 6S 17.8% for Hs6st1 f/f ;Hs6st2 −/− ; NS 66.3%, 2S 26.4%, and 6S 0.08% for Hs6st1 −/− ;Hs6st2 −/− ) ( Fig. 2g , Table 1 ). Sulf1 −/− ;Sulf2 −/− HS showed an increase in 6S with reductions in NS and 2S-an effect opposite that observed in Hs6st1 −/− ;Hs6st2 −/− cells (NS 55.4%, 2S 18.6%, and 6S 20.4% for Sulf1 f/f ;Sulf2 f/f versus NS 50.5%, 2S 14.2%, and 6S 27.2% for Sulf1 −/− ;Sulf2 −/− ) ( Fig. 2h , Table 1 ). HS in the Hs6st1 −/− , Hs6st1 f/f ;Hs6st2 −/− , Hs6st1 −/− ;Hs6st2 −/− , and Sulf1 −/− ;Sulf2 −/− lines had a normal overall sulfation level. Cells with knockout of Hs6st and Sulf genes could thus be used to specifically determine the necessity of 6S, or of higher 6S levels relative to the overall sulfation, for ligand binding and downstream signaling.
In the Hs3st-gene mutants, Hs3st1 −/− HS had a normal HS disaccharide composition, whereas Hs3st4 −/− and Hs3st1 −/− ;Hs3st4 −/− HS Eighteen MLEC lines were generated, including 5 'wild-type' (WT; in which the HS-specific genes were conditionally targeted) and 13 HS-mutant cell lines. The HS-mutant cell lines were derived from conditionally targeted HS gene alleles by Cre recombinase treatment (Cre-loxP gene targeting) or conventional HS mutant alleles, or by direct gene targeting with gRNA (CRISPR-Cas9 approach). WTa, average of the five immortalized WT MLEC lines ( Table 1 ). We were not able to detect 3S in the disaccharide-composition assay and assessed it on the basis of binding of antithrombin, a ligand that strictly requires HS 3S for binding. Hs3st1 −/− and Hs3st4 −/− MLECs both showed reduced antithrombin binding compared with that in controls, and this effect was even more pronounced in Hs3st1 −/− ;Hs3st4 −/− cells ( Fig. 2j,k) , indicating that Hs3st1 and Hs3st4 deletion each reduce 3S. Hs3st4 −/− and Hs3st1 −/− ;Hs3st4 −/− HS, but not Hs3st1 −/− HS, showed slightly reduced overall sulfation compared with that in controls (Hs3st4 −/− , -10.6%; Hs3st1 −/− ;Hs3st4 −/− , -12.3%) ( Fig. 2i ). Hs6st1 −/− , Hs6st1 f/f ;Hs6st2 −/− , Hs6st1 −/− ;Hs6st2 −/− , and Sulf1 −/− ;Sulf2 −/− HS had normal overall sulfation compared with that in the respective control lines. Thus, the combined examination of cells with mutations in Hs6st, Sulf, and Hs3st genes could allow researchers to determine and differentiate the importance of 3S, 6S, and overall sulfation for ligand binding and downstream signaling activation in these cells. As a whole, the generated MLEC library harbors alterations of all HS modification types and might allow for determination of the necessity of specific modifications and overall HS sulfation levels for ligand binding and subsequent downstream signaling activation.
The importance of fine structure versus sulfation level of HS for FGF2-FGFR1 signaling. HS functions as a coreceptor for FGF signaling by interacting with FGF and FGFR to form functional FGF-HS-FGFR ternary complexes on the cell surface. FGF2 is one of the most studied HS-binding ligands, yet there is still debate about the relative importance of HS specific modifications and overall sulfation levels for FGF2 binding. Affinity binding and crystallography studies have demonstrated the necessity of NS and 2S for FGF2 binding, whereas 6S is required only to bridge FGF2 and FGFR for effective signaling activation, and not for FGF2 binding [13] [14] [15] [16] . Biochemical studies also demonstrated that distinct HS structures differentially regulate FGF2 signaling via different FGFRs in a manner not related to sulfation level, which supports the idea that sulfation patterns are crucial 17 . However, some biochemical studies 6, 7, 18 , in particular a genetic study of HS-mutant Drosophila 8 , have suggested that the overall sulfation level is more important for FGF signaling than strictly defined HS fine structures are. Considering that HS deficiency in vivo can potentially affect multiple signaling pathways simultaneously, we reasoned that direct stimulation of HS-mutant MLECs, which expressed only FGFR1 at comparable levels among the cell lines used in this study (Supplementary Figs. 5-7), with FGF2 might allow this fundamental issue to be better addressed.
We assessed cell-surface FGF2 binding by flow cytometry after staining the cells with biotinylated FGF2. We assessed FGFR1 activation by measuring Erk1/2 phosphorylation. Deletion of Ndst1, Ndst2, or both Ndst1 and Ndst2 reduced NS levels and overall sulfation levels compared with those in controls. After FGF2 staining, the reductions in cell-surface FGF2 binding on Ndst1 −/− , Ndst1 f/f ;Ndst2 −/− , and Ndst1 −/− ;Ndst2 −/− MLECs correlated with the levels of NS and overall sulfation in those cells, as well as with attenuated Erk1/2 phosphorylation ( Fig. 3a , Table 2 , Supplementary Figs. 8 and 9 ), which implies that certain levels of NS, overall sulfation, or both are required for HS to facilitate FGF2-FGFR1 signaling. Because Ndst1 deletion also led to reduced 2S and 6S, examinations of Hs2st1 −/− and Hs6st1 −/− ;Hs6st2 −/− cells are needed to better determine the importance of HS NS for FGF2-FGFR1 signaling.
Deletion of Glce and Hs2st1 decreased epimerization and 2S, respectively, but slightly increased the overall sulfation of the mutant HS compared with that in controls. Glce −/− and Hs2st1 −/− MLECs both showed significantly reduced FGF2 binding and attenuated downstream signaling compared with that in controls ( Fig. 3b ,c, Table 2 , Supplementary Figs. 8 and 9 ), indicating that IdoA and 2S modifications are more important than the overall sulfation level for FGF2-FGFR1 signaling.
Deletion of Hs6st1 reduced only 6S levels, and deletion of Hs6st2 did not affect the HS disaccharide composition, whereas double deletion of Hs6st1 and Hs6st2 led to decreased 6S along with increased NS and 2S. Deletion of Hs6st1, Hs6st2, or both did not alter the overall sulfation level. The Hs6st1 −/− , Hs6st1 f/f ;Hs6st2 −/− , and Hs6st1 −/− ;Hs6st2 −/− mutants showed increased cell-surface FGF2 binding compared with that in controls, and this change correlated with unchanged, increased, and attenuated Erk1/2 phosphorylation, respectively ( Fig. 3d , Table 2 , Supplementary Figs. 8  and 9 ). Double deletion of Sulf1 and Sulf2 increased 6S but did not alter the overall sulfation. The Sulf1 −/− ;Sulf2 −/− MLECs showed reduced FGF2 binding and slightly attenuated Erk1/2 phosphorylation compared with that in controls ( Fig. 3e , Table 2 , Supplementary  Figs. 8 and 9 ). Therefore, the examination of cells with mutations in Hs6st and Sulf genes demonstrated that 6S is more important than the overall sulfation for FGF2 signaling and that proper 6S is required for HS to effectively facilitate FGF2 signaling. These observations also exemplify that cell-surface FGF2-binding capacity does not necessarily correlate positively with downstream signaling activation. Furthermore, Hs6st2 −/− cells had a normal HS disaccharide composition but showed altered FGF2 binding and downstream signaling activation, which suggests that Hs6st2 deletion alters the sulfated domains in HS.
Reduced cell-surface antithrombin binding indicated that deletion of Hs3st1 or Hs3st4 alone or of both Hs3st1 and Hs3st4 reduced 3S. Deletion of Hs3st4, but not of Hs3st1, and double deletion of Hs3st1 and Hs3st4 also substantially reduced 6S and slightly reduced the overall sulfation compared with that in controls. Cell-surface FGF2 binding was increased on Hs3st4 −/− MLECs but remained unchanged on Hs3st1 −/− and Hs3st1 −/− ;Hs3st4 −/− MLECs, and all the Hs3st-mutated MLECs showed normal Erk1/2 phosphorylation after FGF2 stimulation (Fig. 3f , Table 2 , Supplementary Figs. 8  and 9 ). These results show that 3S is dispensable for HS facilitation of FGF2 signaling and demonstrate again that increased cell-surface FGF2 binding does not positively correlate with enhanced FGF2 signaling activation.
Our results demonstrate that NS, IdoA, and 2S are essential for HS binding to FGF2, but only in the presence of proper 6S modification can this binding effectively facilitate FGF2-FGFR1 signaling activation. Our data support the idea that HS fine structure is more important than overall sulfation for FGF2-FGFR1 signaling.
Characterization of anti-HS phage display antibody epitopes.
Anti-HS phage display antibodies are commonly used to probe HS structure expression in tissue in situ 19 . However, their putative epitopes have been determined only on the basis of their binding capacity for chemically modified heparins and a limited number of synthetic HS oligosaccharides 20, 21 . To address this, we examined our mutant library using the common anti-HS phage display antibodies AO4B08, EV3C3V, RB4EA12, and HS4C3 (Fig. 4a) [19] [20] [21] [22] [23] [24] . We analyzed the mutant MLECs for antibody binding to cell-surface HS by flow cytometry. We observed positive staining for all four antibodies in Ext1 f/f cells (Fig. 4b) . Epitopes recognized by AO4B08 and EV3C3 are more abundant than the ones recognized by HS4C3 and RB4EA12. Compared with binding to Ext1 f/f cells, antibody binding to Ext1 −/− cells was largely lost for EV3C3, HS4C3, and RB4EA12, and was partially lost for AO4B08 ( Fig. 4b) , which shows that these antibodies indeed bind native HS.
Previous biochemical studies established that the AO4B08binding epitope contains NS, 6S, IdoA, and an internal 2-O-sulfated IdoA residue 20,21,24 (Fig. 4a ). In agreement with these reports, we observed that binding of AO4B08 was reduced on Ndst1 −/− , (Fig. 4c-i) . The binding of AO4B08 to Hs3st1 −/− , Hs3st4 −/− , and Hs3st1 −/− ;Hs3st4 −/− MLECs was also reduced (Fig. 4j ), which indicates that the AO4B08 epitope contains 3S.
Biochemical studies have also shown that the EV3C3 epitope contains NS, IdoA, and 2S, and prefers a low level of 6S for good binding 20 (Fig. 4a ). Compared with binding in controls, we observed reduced EV3C3 binding on (Fig. 4c-h) , which indicates that the EV3C3 epitope does contain NS, IdoA, 2S, and 6S. We noted increased EV3C3 binding to Sulf1 −/− ;Sulf2 −/− MLECs, which expressed HS with increased levels of 6S (Fig. 4i) , thus indicating that higher 6S levels do not interfere with EV3C3 binding. These observations suggest that 6S is an essential component of the EV3C3 epitope. Binding of EV3C3 to Hs3st1 −/− , Hs3st4 −/− , and Hs3st1 −/− ;Hs3st4 −/− MLECs also was reduced (Fig. 4j) , which indicates that the EV3C3 epitope contains 3S. Biochemical studies have shown that the HS4C3 epitope contains NS, 2S, 6S, and 3S 19, 22 (Fig. 4a ). In agreement with these observations, we found that HS4C3 showed reduced binding on Ndst1 −/− , Ndst1 f/f ;Ndst2 −/− , Ndst1 −/− ;Ndst2 −/− , Hs6st1 −/− , Hs6st1 f/f ;Hs6st2 −/− , Hs6st1 −/− ;Hs6st2 −/− , Hs3st1 −/− , Hs3st4 −/− , and Hs3st1 −/− ;Hs3st4 −/− MLECs, but increased binding on Sulf1 −/− ;Sulf2 −/− MLECs (Fig. 4c,d,g-j) . However, the binding of HS4C3 to Hs2st1 −/− MLECs was unchanged compared with that in controls ( Fig. 4f) , indicating that the HS4C3 epitope does not necessarily have to contain the 2S modification. In addition, the binding of HS4C3 to Glce −/− MLECs was reduced compared with that in controls ( Fig. 4e) , which indicates that IdoA is an essential component of the HS4C3 epitope.
Previous biochemical studies determined that the RB4EA12 epitope contains N-acetylated and N-sulfated glucosamine residues with 6S modification 20 (Fig. 4a ). This was supported in our study by reduced RB4EA12 binding on Ndst1 −/− , Ndst1 f/f ;Ndst2 −/− , Ndst1 −/− ;Ndst2 −/− , Hs6st1 −/− , Hs6st1 f/f ;Hs6st2 −/− , and Hs6st1 −/− ;Hs6st2 −/− MLECs and increased binding on Sulf1 −/− ;Sulf2 −/− MLECs (Fig. 4c,d ,g-i). Hs2st1 −/− MLECs showed normal RB4EA12 binding compared with that in controls ( Fig. 4f) , indicating that the native HS epitope recognized by RB4EA12 does not necessarily have to contain 2S, in agreement with the reported biochemical analysis. RB4EA12 showed reduced binding to Glce −/− , Hs3st1 −/− , Hs3st4 −/− , and Hs3st1 −/− ;Hs3st4 −/− MLECs (Fig. 4e-j) , which suggests that the RB4EA12 epitope also contains IdoA and 3S.
Our HS-mutant cell-staining study determined the structural features of the native HS epitopes recognized by the four anti-HS phage antibodies, which, in most cases, were in good agreement with reported biochemical studies ( Supplementary Table 1 ). However, we observed several discrepancies, including the requirement of 6S for EV3C3 and the lack of a requirement for 2S for HS4C3. In addition, we observed that 3S was a component of native HS epitopes for AO4B08, EV3C3, and RE4EA12. The 3S might have been additive, as the Hs3st1 −/− , Hs3st4 −/− , and Hs3st1 −/− ;Hs3st4 −/− MLECs showed only reduced antibody binding. Furthermore, the epitopes for HS4C3 and RB4EA12 also contained IdoA.
Characterization of the HS modification network in HS fine structure expression. HS biosynthesis is generally referred to as a sequential process consisting of initiation by copolymerases Ext1 and Ext2 followed by modification reactions initiated by Ndst-family enzymes and proceeded by Glce, Hs2st, Hs6st-family, and Hs3stfamily enzymes. The biosynthesized HS is further subjected to extracellular remodeling by Sulf-family enzymes 5, 9 . In HS composition analysis, we noticed that inactivation of an individual HS enzyme also affected upstream and/or downstream modifications that were not catalyzed by the mutant enzyme, which indicated that internal HS-modification network regulation exists in MLECs. We therefore correlated the disaccharide composition of the mutant HS with HS gene expression in the mutant cells to better understand the intermodification network regulation in MLECs.
Deletion of Ndst1 led to upregulation of Ndst3, Hs6st1, and Hs3st4 but downregulation of Hs2st1 (Fig. 5a ). Ndst2 deletion did not affect the expression of other Ndst genes, but it led to upregulation of Hs2st1, Hs3st4, and Sulf1 (Fig. 5b) , thus showing that Ndst1 and Ndst2 have distinct regulation effects on other modification genes. Ndst1 deletion reduced levels of NS and 6S but upregulated Ndst3 and Hs6st1. Similarly, Ndst2 deletion had no effect on 2S and 6S and upregulated Hs2st1 and Sulf1. These observations indicate that, at the NS step, the modification network regulation occurs at the transcriptional level but contributes minimally to HS fine structure expression. Furthermore, simultaneous deletion of Ndst1 and Ndst2 diminished the network regulation, except for slight Ndst3 upregulation ( Fig. 5c , Supplementary Fig. 10a ), indicating that the modification network regulation essentially depends on the expression of Ndst genes.
Glce deletion led to upregulation of Ndst1, Ndst2, Hs2st1, Hs6st1, and Sulf2, correlating with increased NS and 6S of HS (Fig. 5d ), which indicates inhibitory regulation by Glce of NS and 6S via downregulation of Ndst1, Ndst2, and Hs6st1. Increased 6S in Glce −/− HS also indicated that the upregulation of Sulf2 contributes minimally to 6S modification.
Hs2st1 deletion led to upregulation of Ndst2, Glce, Hs6st1, Hs6st2, Hs3st1, Hs3st4, Hs3st6, Sulf1, and Sulf2 (Fig. 5e ), thus revealing profound inhibition by Hs2st1 of other modification genes. Similar to Glce deletion, Hs2st1 deletion led to increased NS and 6S, indicating that Hs2st1 inhibits NS and 6S by downregulating Ndst2, Hs6st1, and Hs6st2, and that the contributions of upregulated Sulf1 and Sulf2 remain minimal.
Hs6st1 deletion upregulated Ndst1, Hs2st1, Hs3st1, Sulf1, and Sulf2 but did not affect NS and 2S (Fig. 5f ). Hs6st2 deletion upregulated Hs6st1 and Hs3st1 but did not alter 6S, NS, or 2S ( Fig. 5g , Supplementary Fig. 10b ). However, simultaneous deletion of Hs6st1 and Hs6st2 led to upregulation of Ndst1, Ndst2, Hs2st1, Hs3st1, and Sulf2 (Fig. 5h ), which correlated with increased NS and 2S, thus revealing inhibition of NS and 2S modification by Hs6st genes through suppression of Ndst1, Ndst2, and Hs2st1 expression.
Hs3st1 deletion led to slight upregulation of Ndst2 but downregulation of Hs2st1 and Hs3st4 (Fig. 5i) , and did not alter HS composition. Hs3st4 deletion led to slight upregulation of Ndst1, Ndst2, and Hs3st1; slight downregulation of Hs2st1; and high upregulation of Sulf2 (Fig. 5j ), which correlated with reduced 6S. Simultaneous deletion of Hs3st1 and Hs3st4 showed regulatory effects similar to those of Hs3st4 deletion (Fig. 5k, Supplementary Fig. 10c-e ), except for slight Hs6st1 upregulation, indicating that, within the Hs3st-family genes expressed in MLECs, Hs3st4 plays the major role in negative regulation of the modification network and has an overall role in increasing 6S.
Simultaneous deletion of Sulf1 and Sulf2 led to downregulation of Ndst1, Ndst2, and Hs2st1, and upregulation of Glce and Hs3st1 (Fig. 5l ), which correlated with reduced NS and 2S, indicating positive regulation by Sulf genes of NS and 2S and negative regulation of epimerization and 3S. Furthermore, the increased 6S levels in Sulf1 −/− ;Sulf2 −/− HS indicated that the overall 6S level is critically regulated by Sulf genes in MLECs.
In all, our systematic study reveals the following: (1) In MLECs, Ndst genes are essentially required in order for intermodification network regulation to occur, in good agreement with the modification-initiation function of Ndst genes in HS biosynthesis. (2) Glce, 
FGF2-FGFR1 signaling activation was assessed by measurement of downstream Erk1/2 phosphorylation. ↑ , increased; ↓ , attenuated; ~, slight alteration that did not reach statistical significance.
Hs2st1, Hs6st genes, and Hs3st genes reciprocally inhibit non-selfmodification at the gene-expression and HS-composition levels.
(3) Sulf genes positively regulate NS and 2S, but negatively regulate epimerization and 3S.
Regulation of HS chain length by HS gene expression. Ndst2, but not Ndst1, was reported to regulate HS chain length 25 . Currently we lack a systematic view of the HS chain-length regulation by HS genes. In PAGE analysis of intact HS, we determined that Ndst1 −/− and Hs3st1 −/− ;Hs3st4 −/− HS had normal chain lengths compared with those in controls, whereas Ndst2 −/− , Glce −/− , Hs6st1 f/f ;Hs6st2 −/− , and Hs3st1 −/− HS became shorter, and Ndst1 −/− ;Ndst2 −/− , Hs2st1 −/− , Hs6st1 −/− , Hs6st1 −/− ;Hs6st2 −/− , and Hs3st4 −/− HS became longer ( Supplementary Fig. 11 ). A comparison of single-and double-gene-deficient HS showed that for genes in the same family, including Ndst1 and Ndst2, Hs6st1 and Hs6st2, and Hs3st1 and Hs3st4, the two expressed genes had opposite regulation effects on HS chain length and reciprocally inhibited each other. All examined HS genes regulated HS chain length, and this regulation could be positive or negative, as well as direct or indirect.
Discussion
Examination of HS-mutant cells is an effective and straightforward approach for determining the function and structure-function relationships of native HS in a biological setting. This type of study was originally carried out with chemical-mutagenesis-generated HS-mutant CHO cell lines [26] [27] [28] . Currently only four CHO HS-mutant cell lines are available. CHO cells do not express Hs3st genes and cannot be used to examine 3S-related modifications 29, 30 . CHO cells also lack endogenous expression of many HS-dependent signaling receptors, such as FGFR, receptors for vascular endothelial growth factor (VEGF), and Slit; very limited cellular function information has been obtained with these mutant CHO cells. Our examination of Ndst1 −/− and Ndst1 f/f MLEC lines determined that NS is required for HS to function as a coreceptor for VEGF and Slit3 signaling [31] [32] [33] [34] . The success of previous studies and the FGF signaling coreceptor study described here demonstrate that our HS-mutant MLEC library represents a powerful platform for examining the roles and the structure-function relationship of HS in a cellular context, and findings could potentially be correlated with in vivo findings in corresponding mutant mice. In addition, our study demonstrates CRISPR-Cas9 technology as a highly efficient approach to generate HS-mutant MLECs and is expected to be applicable to other cell types for the generation of HS mutants. HS functions as a coreceptor for FGF signaling by interacting with both FGF and FGFR. A number of biochemical studies have shown that interactions of HS with FGFs require unique structures in which NS, 2S, and 6S contribute to the generation of specific sulfation patterns [15] [16] [17] [35] [36] [37] . Crystallographic studies showed that 2S and 6S form hydrogen bonds with heparin-binding residues of FGFs and/or FGFRs to induce dimerization of FGFRs 14 . Meanwhile, other studies reported that FGF binding to HS is dictated primarily by the overall sulfation level, rather than by the precise positioning of various sulfate groups 7, 8, 18 . We observed that MLECs with knockout of Glce, Hs2st1, Hs6st-family genes, and Sulf-family genes, which express only FGFR1, showed altered FGF2 binding and downstream signaling activation, even though the mutants had normal or slightly increased HS overall sulfation. Our results support the idea that HS fine structure is more important than overall sulfation for FGF2-FGFR1 signaling activation.
HS phage display antibodies have been widely applied to probe HS structure in various tissues in situ 19, 21, 38 . However, their native HS epitope structures remain largely unclear 21, 39 . Using our HS-mutant cell library, we found that (1) the EV3C3 epitope involves 6S, and a natural increase in 6S levels does not inhibit antibody binding;
(2) the HS4C3 epitope does not necessarily contain 2S but requires IdoA; and (3) the epitopes for AO4B08, EV3C3, and RB4EA12 also require 3S. The involvement of rare 3S suggests that the antibodies may function in the 'all-or-nothing' high-specific-binding mode 40 , thus supporting the application of the antibodies as high-affinity probes for specific HS structures in situ. Further studies with a comprehensive, synthesized, 3S-containing HS library might help further define the epitope structures.
Studies of Hs2st1-deficient CHO cells and mouse fibroblasts 41,42 and HS-deficient Drosophila 8 and Caenorhabditis elegans 43 revealed an inter-regulatory modification network in HS biosynthesis. Systematic perturbation of HS-modification genes in C. elegans led to the proposal of an inter-regulation model of modification enzymes in HS biosynthesis in metazoans: Glce, Hs2st1, and Hs6stfamily genes inhibit NS; Glce stimulates both 2S and 6S; Hs2st1 and the Hs6st genes inhibit 6S and 2S, respectively; and 6S is inhibited by Sulf1 43 . We observed similar inter-regulation in MLECs, except for Glce, which stimulated 2S but inhibited 6S, and Sulf genes, which also stimulated 2S. The discrepancy might be due to the fact that we examined only MLECs, whereas the C. elegans study examined the whole model organism. We also examined Ndst and Hs3st genes, and found that the inter-regulation network essentially depends on the expression of Ndst genes, and that Hs3st4 stimulates 6S. In addition, we also observed that HS genes generally regulated HS chain length, by either elongating or shortening the chain, and HS genes within same family normally acted reciprocally to regulate HS chain length. These studies provide a comprehensive and systematic view of the inter-regulation of HS genes in mammalian cells at specific cell-type, transcription, and HS-structure levels. HS expression is cell-type specific, and similar studies with other cell types might determine whether our observed inter-regulation of HS expression is common in mammalian cells.
In the current study, HS structure analyses determined disaccharide composition and chain length, but not sequence, which plays the central role underpinning the structure-function relationship of HS. This should be examined once capable technology becomes available in the future.
online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/ s41592-018-0189-6. Corresponding author(s): Lianchun Wang Life Sciences Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form is intended for publication with all accepted life science papers and provides structure for consistency and transparency in reporting. Every life science submission will use this form; some list items might not apply to an individual manuscript, but all fields must be completed for clarity.
For further information on the points included in this form, see Reporting Life Sciences Research. For further information on Nature Research policies, including our data availability policy, see Authors & Referees and the Editorial Policy Checklist.
Please do not complete any field with "not applicable" or n/a. Refer to the help text for what text to use if an item is not relevant to your study. For final submission: please carefully check your responses for accuracy; you will not be able to make changes later.
Experimental design 1. Sample size
Describe how sample size was determined.
No sample size calculation was performed since the this is cell line study.
Data exclusions
Describe any data exclusions.
One transcript data of a triple repeat was excluded due to obvious abnormal value (less than mean of the triple-3xSD)
Replication
Describe the measures taken to verify the reproducibility of the experimental findings.
The reproducibility of our experimental finding were confirmed by at least three independent repeat experiments.
Randomization
Describe how samples/organisms/participants were allocated into experimental groups.
No randomization was performed as the study are based on cells in different genotype.
Blinding
Describe whether the investigators were blinded to group allocation during data collection and/or analysis.
The heparan sulfate disaccharide, gene transcript and FGF2 signaling analyses were blind to the investigators. However, the cell surface staining for CD31, VEGFR2, anti-heparan sulfate phage display antibodies and genotyping were not blind to the investigators, because these information were needed essentially to generate the heparan sulfate mutant cell library.
Note: all in vivo studies must report how sample size was determined and whether blinding and randomization were used.
Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the Methods section if additional space is needed).
n/a Confirmed
The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same sample was measured repeatedly A statement indicating how many times each experiment was replicated The statistical test(s) used and whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
Test values indicating whether an effect is present
Provide confidence intervals or give results of significance tests (e.g. P values) as exact values whenever appropriate and with effect sizes noted.
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars in all relevant figure captions (with explicit mention of central tendency and variation)
See the web collection on statistics for biologists for further resources and guidance.
